WA
WST icon

Westfuller Advisors’s West Pharmaceutical WST Stock Holding History

Westfuller Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.54K Hold
10
– – ﹤0.01% 611
2025
Q4 		$2.78K Hold
10
– – ﹤0.01% 631
2025
Q3 		$2.65K Buy
+10
New +$2.43K ﹤0.01% 612

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westfuller Advisors's WST Position: Q1 2026 in Review

Westfuller Advisors held its West Pharmaceutical (WST) position steady in Q1 2026 at 10 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Westfuller Advisors first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.78K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Westfuller Advisors held 10 shares of West Pharmaceutical worth $2.54K as of Q1 2026.
  • Westfuller Advisors left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Westfuller Advisors's portfolio in Q1 2026, its #611 holding.
  • Westfuller Advisors first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's West Pharmaceutical position peaked at $2.78K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.